Search Results 141-150 of 16836 for Amphotericin B
Mughrabi A, Chesdachai S, Bisono Garcia B, Lemke A, Ranganath N, Razonable RR. Real-World Off-Label Use of Letermovir Prophylaxis for Cytomegalovirus ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.
Bartlett, M.B., B.Ch., B.A.O.. Internist. Rochester, MN. Areas of focus: Antiphospholipid syndrome, Deep vein thrombosis, Pulmonary ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...
... B Cell Lymphocytosis (MBL) and B-Chronic Lymphocytic Leukemia (CLL) patients. A Registry for Children Treated with Proton Radiation Therapy. Rochester, Minn ...
Ryan RJ, Bentall AJ, Issa N, Dean PG, Smith BH, Stegall MD, Riad SM. Outcomes of Older Primary Kidney Transplant Recipients by Induction Agent and High-risk ...
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
2022; doi:10.1038/s41577-021-00547-6. Derman B, et al. Real-world evidence evaluating teclistamab in patients with relapsed/refractory multiple myeloma: A ...
Giving paclitaxel albumin-stabilized nanoparticle formulation and rituximab may work better in treating patients with B-cell non-Hodgkin lymphoma. Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.